Merck

Who are Gilead Sciences' (GILD) main competitors?
Investopedia
Fri, 05/22/15 - 10:56 am
Gilead Sciences
GSK
Pfizer
AbbVie
Merck
Bristol-Myers Squibb
FDA's SGLT2 warning bad news for AZ, J&J and Lilly--but could be a boon for Merck
Fierce Pharma
Mon, 05/18/15 - 09:40 pm
FDA
SGLT2 inhibitor
AstraZeneca
JNJ
Eli Lilly
Merck
diabetes
The top 10 advertisers in Big Pharma
Fierce Pharma Marketing
Mon, 05/18/15 - 11:27 am
Pfizer
AbbVie
AstraZeneca
Eli Lilly
JNJ
Actavis
Merck
Bristol-Myers Squibb
Dainippon Sumitomo
Amgen
drug ads
10 Important Checkpoint Inhibitor Cancer Drug Abstracts from ASCO '15
TheStreet.com
Fri, 05/15/15 - 11:05 am
ASCO
cancer
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Roche
Genentech
MPDL3280A
MEDI4736
AstraZeneca
Merck scores victory in India patent battle over top diabetes meds
Fierce Pharma
Fri, 05/15/15 - 11:03 am
Merck
India
patents
diabetes
Glenmark
Januvia
Janumet
ASCO cancer research data drop: What to watch
CNBC
Wed, 05/13/15 - 12:18 pm
ASCO
oncology
cancer
Merck
Bristol-Myers Squibb
AstraZeneca
Juno Therapeutics
CAR-T
Ibrance
Pfizer
elotuzumab
Opdivo
Keytruda
Lucky 7 diabetes meds to join blockbuster club by 2020
Fierce Pharma Marketing
Tue, 05/12/15 - 04:27 pm
diabetes
Sanofi
Lantus
Merck
Januvia
Eli Lilly
Humalog
Novo Nordisk
Xultophy
Tresiba
4 Pharmaceutical Companies Leading the Breast Cancer Fight
24/7 Wall St
Fri, 05/8/15 - 10:48 am
breast cancer
Merck
Bristol-Myers Squibb
Medivation
Pfizer
The Q1 drug launch scorecard, starring Sanofi, Lilly, Pfizer, Gilead, Merck and more
Fierce Pharma Marketing
Mon, 05/4/15 - 04:43 pm
earnings
Sanofi
Eli Lilly
Pfizer
Gilead Sciences
Merck
AbbVie
Merck antibiotic combo Zerbaxa shows efficacy in complicated infections
BioPharma Dive
Fri, 05/1/15 - 09:14 am
Merck
Zerbaxa
complicated urinary tract infections
Merck Gains Edge on Rivals With Results About its Diabetes Drug
WSJ Pharmalot
Wed, 04/29/15 - 09:20 am
Merck
diabetes
Januvia
AstraZeneca
Onglyza
Nesina
How Big Can Merck's Keytruda Be In Lung Cancer?
Forbes
Tue, 04/28/15 - 09:03 pm
Merck
Keytruda
lung cancer
FDA bats down Merck's sugammadex in third rejection
Fierce Biotech
Tue, 04/28/15 - 09:01 pm
FDA
Merck
sugammadex
Bridion
Cardiovascular Outcomes With Merck's Januvia: No Better Or Worse Than Conventional Care
Forbes
Tue, 04/28/15 - 09:41 am
Merck
Januvia
diabetes
Merck shares up 4.5% as company beats profit, sales estimates and raises outlook
Marketwatch
Tue, 04/28/15 - 08:50 am
Merck
earnings
Gilead Will Keep Hepatitis C Dominance In Its Grip With Recent Trial Results
Seeking Alpha
Tue, 04/28/15 - 08:49 am
Gilead Sciences
Harvoni
hepatitis C
AbbVie
Bristol-Myers Squibb
Merck
Achillion
Merck Earnings: What to Watch
WSJ Online
Mon, 04/27/15 - 09:18 pm
Merck
earnings
Analyst: Biogen Will Miss On Tecfidera Sales; No Threat To Gilead's Harvoni
Yahoo/Benzinga
Fri, 04/24/15 - 10:35 am
Biogen
Tecfidera
Merck
Gilead Sciences
grazoprevir/elbasvir
Harvoni
hepatitis C
Merck and Gilead square off in battle of the next-next-gen hep C combos
Fierce Biotech
Thu, 04/23/15 - 09:50 am
Merck
Gilead Sciences
hepatitis C
grazoprevir/elbasvir
GS-5816
GS-9857
Bullied in Norway, Merck Sees Sales of Blockbuster Dive
Bloomberg
Thu, 04/23/15 - 03:22 am
Merck
rheumatoid arthritis
Norway
Europe
Remicade

Pages